Targeting MCF-7 Cell Line by Listeriolysin O Pore Forming Toxin Fusion with AHNP Targeted Peptide

BACKGROUND: Tumor-targeting peptides are attracting subjects in cancer therapy. These peptides, which are widely studied, deliver therapeutic agents to the specific sites of tumors. In this study, we produced a new form of recombinant listeriolysin O (LLO) with genetically fused Anti-HER2/neu peptid...

Descripción completa

Detalles Bibliográficos
Autores principales: Fotoohi-Ardakani, Gholamreza, Kheirollahi, Majid, Zarei Jaliani, Hossein, Noorian, Mohadese, Ansariniyia, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543864/
https://www.ncbi.nlm.nih.gov/pubmed/31259162
http://dx.doi.org/10.4103/abr.abr_18_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543864/
https://www.ncbi.nlm.nih.gov/pubmed/31259162
http://dx.doi.org/10.4103/abr.abr_18_19

Ejemplares similares